Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Hydrocortisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Leukemia 22 Prostatic Neoplasms 19 Burkitt Lymphoma 13 Leukemia, Biphenotypic, Acute 11 Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Lymphoma, Non-Hodgkin 5 Recurrence 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Pancreatic Neoplasms 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Hodgkin Disease 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Polycystic Ovary Syndrome 2 Pituitary Neoplasms 2 Obesity 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory 2 Stomatitis 1 Stomach Neoplasms 1

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Electrocardiography 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡